Cargando…
Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention
BACKGROUND: Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the pathogenesis of restenosis. We investigated whether...
Autores principales: | Kullmann, Silke, Binner, Priska, Rackebrandt, Kirsten, Huge, Andreas, Haltern, Georg, Lankisch, Mark, Füth, Reiner, von Hodenberg, Eberhard, Bestehorn, Hans-Peter, Scheffold, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767343/ https://www.ncbi.nlm.nih.gov/pubmed/19814804 http://dx.doi.org/10.1186/1471-2261-9-48 |
Ejemplares similares
-
Six sequence variants on chromosome 9p21.3 are associated with a positive family history of myocardial infarction: a multicenter registry
por: Scheffold, Thomas, et al.
Publicado: (2011) -
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010) -
Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022) -
Inhibition of Soluble Epoxide Hydrolase for Renal Health
por: Liu, Jun-Yan
Publicado: (2019) -
Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
por: Domingues, Michelle Flores, et al.
Publicado: (2020)